Loading the records…
Loading the records…
The VISIT USA Act (HR6128) proposes a $160 million transfer from the Travel Promotion Fund to Brand USA for international tourism promotion. The bill is in early legislative stages—referred to committee with a companion Senate bill. Market impact is negligible at this stage due to procedural uncertainty and lack of direct corporate beneficiaries.
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
At $160 million, this bill's market impact is negligible for any publicly traded company. The travel and tourism sector has no direct contractual link to Brand USA's promotional activities. Investors should treat this as a procedural non-event until substantive committee action occurs. No actionable trades are indicated by this legislation in its current form.
The VISIT USA Act was introduced in the House on November 19, 2025, and referred to the House Committee on Energy and Commerce. It has an identical companion bill (S3220) in the Senate. The bill authorizes a one-time transfer of $160 million from unobligated balances in the Travel Promotion Fund—derived from fee collections under immigration law—to Brand USA, a nonprofit corporation. This is not an appropriation; it releases existing funds subject to Brand USA's matching requirement and carryforward provisions. No new funding source is created.
The money trail runs from the Treasury to Brand USA, which uses funds to market the U.S. as a tourist destination. While increased tourism could benefit airlines, hotels, and travel intermediaries, this is a small incremental budget (roughly 10-15% of Brand USA's recent annual budgets) and is not tied to specific procurement or contracts. No publicly traded company is directly obligated or receives a guaranteed revenue stream from this bill.
Competitive landscape: Hotel operators (Marriott, Hilton), airlines (Delta, United, American), and online travel agencies (Booking Holdings, Expedia) could see marginal demand lift if promotions are effective, but the mechanism is indirect and the amount is immaterial relative to these companies' revenues. No pure-play tourism promotion firms trade publicly.
Timeline: The bill remains in early committee stage with no hearings scheduled. Passage requires House Energy and Commerce markup, full House vote, Senate companion action (S3220) through Commerce, Science and Transportation Committee, conference if different versions, and presidential signature. Given the limited legislative calendar remaining in the 119th Congress (ends January 2027), odds of enactment are moderate but uncertain.
Matched on shared policy language across AI analyses, with ticker & timing weight
Executive orders & memoranda affecting the same sectors or companies
This proclamation modifies the list of Canadian products subject to a 50% additional ad valorem duty imposed under Section 338 of the Tariff Act of 1930, removing some products from the duty and adding others, effective October 30, 2026. The action is part of an ongoing dispute over Canada's motor vehicle tariff scheme and is intended to offset discrimination against U.S. commerce. The President directs implementation through the Harmonized Tariff Schedule and authorizes U.S. Customs and Border Protection to issue rules.
This executive order directs the Federal Housing Finance Agency to create pilot programs for automatic cancellation of mortgage insurance when borrowers have sufficient equity, and to expand a title insurance pilot to reduce costs for refinancing. It establishes a task force to promote manufactured housing by standardizing permits and reducing regulatory barriers. It also orders the Departments of Agriculture and Veterans Affairs to reduce interest rates on direct home loans.
This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.
Free — no credit card
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →